on 08 Aug 2023
Last Applicant/ Owned by
SE-752 37 Uppsala
SE
Serial Number
79344278 filed on 13th Apr 2022
Registration Number
7129071 registered on 08th Aug 2023
Correspondent Address
Mark H. Tidman
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Scientific laboratory services and scientific research and analysis regarding monitoring and predicting treatment response to cancer therapy, and in viral therapy and autoimmune therapy; scientific laboratory services and research and analysis regarding measuring the activity of enzyme in blood serum or cell cultures; research and development in the field of diagnostic preparations; scientific res Read More
Medical, biomedical and veterinary diagnostic monitoring and testing services regarding blood serum or plasma samples or cell cultures; medical, biomedical and veterinary diagnostic monitoring and testing services regarding measurement of cell proliferation; medical, biomedical and veterinary diagnostic monitoring and testing services regarding measurement of enzymatic activity; provision of medical information and advice relating to the use of medical and veterinary diagnostic equipment; medical testing for diagnostic or treatment purposes, namely, conducting tests to identify diseases affecting cell division, cancer, viral and autoimmune diseases; medical analysis regarding the identification and monitoring of cancer, virus and autoimmune diseases and other diseases that cause cell growth for the diagnosis and treatment of persons
Scientific laboratory services and scientific research and analysis regarding monitoring and predicting treatment response to cancer therapy, and in viral therapy and autoimmune therapy; scientific laboratory services and research and analysis regarding measuring the activity of enzyme in blood serum or cell cultures; research and development in the field of diagnostic preparations; scientific research and development, namely, diagnostic development; data science services, namely, compiling data for research purposes in the field of biostatistics; laboratory biomarker analysis services and related data analysis; biochemical analysis; medical laboratory services; conducting preclinical studies in the nature of scientific feasibility studies; medical laboratory services regarding measurement of cell division; conducting scientific feasibility studies, namely, preclinical studies regarding measurement of cell proliferation; medical laboratory services regarding measurement of enzymatic activity; conducting scientific feasibility studies, namely, preclinical studies regarding measurement of enzymatic activity
Diagnostic agents and reagents, preparations and substances for medical and veterinary purposes for the measurement of cell division; diagnostic agents and reagents, preparations and substances for measuring enzyme activity for medical and veterinary purposes; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in cancer therapy; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in viral diseases; diagnostic kits comprised of medical diagnostic reagents and biomarker assays to monitor and predict treatment response in autoimmune diseases
Diagnostic preparations for scientific or research use; diagnostic agents and reagents for scientific or research use
No 79344278
No Service Mark
No 47727.020087
No
No
No
No
Yes
Yes
No
No
Status Date | Action Taken |
---|---|
13th Nov 2023 | FINAL DISPOSITION PROCESSED |
13th Nov 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
08th Nov 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
08th Aug 2023 | REGISTERED-PRINCIPAL REGISTER |
08th Aug 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
24th May 2023 | NOTIFICATION PROCESSED BY IB |
23rd May 2023 | PUBLISHED FOR OPPOSITION |
23rd May 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
03rd May 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
03rd May 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |